Literature DB >> 18021864

Herpes zoster: epidemiology, natural history, and common complications.

Jeffrey M Weinberg1.   

Abstract

Herpes zoster is a disease associated with aging that can significantly impair quality of life for affected individuals. Anyone infected with varicella (chickenpox) virus in childhood is at risk for reactivation of dormant virus and the onset of zoster disease, although it occurs with increasing frequency in the elderly as a result of waning of cell-mediated immunity. The most common complication of herpes zoster is postherpetic neuralgia, which can cause chronic and debilitating pain. Current treatments can decrease the severity of zoster rash and pain but cannot prevent disease onset or completely eliminate the most frequent symptoms. The zoster vaccine may help prevent the onset of herpes zoster in the target population of those age 60 years and older. This summary reviews the epidemiology, pathogenesis, natural history, and common symptoms of zoster disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021864     DOI: 10.1016/j.jaad.2007.08.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  34 in total

1.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

2.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

3.  In vitro antiviral activity of honey against varicella zoster virus (VZV): A translational medicine study for potential remedy for shingles.

Authors:  Aamir Shahzad; Randall J Cohrs
Journal:  Transl Biomed       Date:  2012

Review 4.  The role of sensory fiber demography in trigeminal and postherpetic neuralgias.

Authors:  A F DaSilva; M F DosSantos
Journal:  J Dent Res       Date:  2011-06-13       Impact factor: 6.116

5.  Zoster duplex: a clinical report and etiologic analysis.

Authors:  Feng Zhang; Jin Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.

Authors:  Anne A Gershon; Michael D Gershon; Judith Breuer; Myron J Levin; Anne Louise Oaklander; Paul D Griffiths
Journal:  J Clin Virol       Date:  2010-05       Impact factor: 3.168

7.  Compliance with herpes zoster vaccination in young and adult individuals in two regions of Italy.

Authors:  Antonino Parlato; Vincenzo Romano Spica; Massimo Ciccozzi; Francesca Farchi; Francesca Gallè; Valeria Di Onofrio; Elisabetta Franco; Giorgio Liguori
Journal:  BMC Public Health       Date:  2010-06-12       Impact factor: 3.295

8.  Herpes zoster eye complications: rates and trends.

Authors:  Barbara P Yawn; Peter C Wollan; Jennifer L St Sauver; Linda C Butterfield
Journal:  Mayo Clin Proc       Date:  2013-05-09       Impact factor: 7.616

9.  Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018.

Authors:  Christina L Kong; Ryan R Thompson; Travis C Porco; Eric Kim; Nisha R Acharya
Journal:  Ophthalmology       Date:  2019-10-09       Impact factor: 12.079

10.  The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study.

Authors:  S J Cotton; J Belcher; P Rose; S K Jagadeesan; R D Neal
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.